摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,7-二(4-羟基苯基)-3,5-庚二醇 | 79120-40-4

中文名称
1,7-二(4-羟基苯基)-3,5-庚二醇
中文别名
——
英文名称
3,5-dihydroxy-1,7-bis(4-hydroxyphenyl)heptane
英文别名
hannokinol;1,7-bis(4-hydroxyphenyl)-3,5-heptanediol;1,7-bis(4-hydroxyphenyl)heptane-3,5-diol
1,7-二(4-羟基苯基)-3,5-庚二醇化学式
CAS
79120-40-4
化学式
C19H24O4
mdl
——
分子量
316.397
InChiKey
GZVIQGVWSNEONZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    156-158℃ (methanol )
  • 沸点:
    570.2±50.0 °C(Predicted)
  • 密度:
    1.225±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    23
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    80.9
  • 氢给体数:
    4
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,7-二(4-羟基苯基)-3,5-庚二醇 生成 4-[2-[6-[2-(4-hydroxyphenyl)ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]phenol
    参考文献:
    名称:
    ALEGRIO, LEILA V.;BRAZ-FILHO, RAIMUNDO;GOTTLIEB, OTTO R., PHYTOCHEMISTRY, 28,(1989) N, C. 2359-2362
    摘要:
    DOI:
  • 作为产物:
    描述:
    (+/-)-5-hydroxy-1,7-bis-(4'-hydroxyphenyl)-3-heptanone 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 生成 1,7-二(4-羟基苯基)-3,5-庚二醇
    参考文献:
    名称:
    桤木木材中的双芳基庚烷类化合物和其他成分
    摘要:
    摘要 桤木 (Alnus japonica) 的木材已被证明含有许多二芳基庚烷类化合物以及其他酚类物质,包括开环异落叶松树脂二铁。环化联芳基庚烷与其相应的无环联芳基庚烷共存已被证明,这一事实可能具有生物合成意义。讨论了双芳基庚烷在桦木科成员中可能的化学分类学重要性。还描述了几种类固醇和三萜类化合物的分离和鉴定。
    DOI:
    10.1016/0031-9422(81)83035-x
点击查看最新优质反应信息

文献信息

  • CURCUMINOID COMPOSITION FOR THERAPEUTIC MANAGEMENT OF METABOLIC SYNDROME
    申请人:Majeed Muhammed
    公开号:US20210106543A1
    公开(公告)日:2021-04-15
    The present invention discloses a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids and its therapeutic application. More specifically, the present invention discloses the use of a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids in the therapeutic management of metabolic syndrome in mammals.
  • CURCUMINOID COMPOSITION AND ITS THERAPEUTIC POTENTIAL IN MANAGING LUNG FIBROSIS
    申请人:Majeed Muhammed
    公开号:US20210106544A1
    公开(公告)日:2021-04-15
    The present invention discloses a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids and its therapeutic application. More specifically, the present invention discloses the use of a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids in the therapeutic management of interstitial lung disease or lung fibrosis.
  • [EN] CURCUMINOID COMPOSITION AND ITS THERAPEUTIC POTENTIAL IN MANAGING LUNG FIBROSIS<br/>[FR] COMPOSITION DE CURCUMINOÏDE ET SON POTENTIEL THÉRAPEUTIQUE DANS LA PRISE EN CHARGE DE LA FIBROSE PULMONAIRE
    申请人:MAJEED MUHAMMED
    公开号:WO2021076771A1
    公开(公告)日:2021-04-22
    The present invention discloses a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids and its therapeutic application. More specifically, the present invention discloses the use of a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w7w hexahydrocurcuminoids and 5%- 10% w7w octahydrocurcuminoids in the therapeutic management of interstitial lung disease or lung fibrosis.
  • [EN] CURCUMINOID COMPOSITION FOR THERAPEUTIC MANAGEMENT OF METABOLIC SYNDROME<br/>[FR] COMPOSITION DE CURCUMINOÏDES DESTINÉE À LA PRISE EN CHARGE THÉRAPEUTIQUE DU SYNDROME MÉTABOLIQUE
    申请人:MAJEED MUHAMMED
    公开号:WO2021076766A1
    公开(公告)日:2021-04-22
    The present invention discloses a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids and its therapeutic application. More specifically, the present invention discloses the use of a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%- 10% w/w octahydrocurcuminoids in the therapeutic management of metabolic syndrome in mammals.
  • Biarylheptanoids and other constituents from wood of Alnus japonica
    作者:Masayasu Nomura、Takashi Tokoroyama、Takashi Kubota
    DOI:10.1016/0031-9422(81)83035-x
    日期:1981.1
    Abstract The wood of Alnus japonica has been shown to contain a number of biarylheptanoids as well as other phenolics, including secoisolariciresinol diferulate. The co-occurrence of cyclized biarylheptanoids with their corresponding acyclic biarylheptanoids has been demonstrated and this fact may have biosynthetic significance. The possible chemotaxonomic importance of biarylheptanoids in members
    摘要 桤木 (Alnus japonica) 的木材已被证明含有许多二芳基庚烷类化合物以及其他酚类物质,包括开环异落叶松树脂二铁。环化联芳基庚烷与其相应的无环联芳基庚烷共存已被证明,这一事实可能具有生物合成意义。讨论了双芳基庚烷在桦木科成员中可能的化学分类学重要性。还描述了几种类固醇和三萜类化合物的分离和鉴定。
查看更多